Antibiotic treatment for neonatal sepsis: changing trends and future directions.

Background: Neonatal sepsis is a serious and life-threatening condition with high morbidity and mortality, especially in preterm neonates in a Neonatal Intensive Care Unit (NICU). This article provides an updated review on the aetiology and diagnosis of neonatal sepsis, antibiotic management and antibiotic stewardship. Methods: A literature search was conducted in PubMed, Embase, Cochrane Library and Scopus in January 2025, using the following MeSH terms: "sepsis", "neonate" and "antibiotic". Meta-analyses, randomized controlled trials, clinical trials and reviews published in the English language from 2005 to 2025 with patients in the neonatal age group were included. A total of 715 articles were identified and screened, and 85 studies were included in the final review. Results: Neonatal sepsis remains a leading cause of mortality, with distinct pathogens identified in early-onset and late-onset sepsis, ventilator-associated pneumonia, urinary tract infection and fungal infections. Early recognition, accurate diagnosis and timely commencement of empirical antibiotics are paramount for improved outcomes. Fungal prophylaxis is considered for at-risk neonates in some NICUs with a high incidence of fungal infection. Universal group B Conclusion: Effective management of neonatal sepsis relies on early pathogen identification, judicious use of antibiotics and good antimicrobial stewardship. Future research directions include development of evidence-based protocols and improvement of rapid diagnostic techniques, combined with close monitoring and individualized care.